Correction: Updated overview of human biomonitoring for beauvericin and enniatins
-
By
-
Gisela H. Degen
-
Anamarija Romac
-
November 13, 2026
By
Gisela H. Degen
Anamarija Romac
November 13, 2026
by Gisela H. Degen, Anamarija Romac
November 13, 2026
Higher medical expenses increased financial anxiety and reduced willingness to schedule recommended procedures in 3 studies, with stronger effects among financially stressed participants.
November 11, 2026
In a randomized trial, additional imaging increased preventive treatment but did not significantly reduce subsequent myocardial infarction or cardiac mortality over 3 years.
November 12, 2026
In a 12,327-patient trial, asundexian cut recurrent ischemic stroke risk by 26% alongside antiplatelets.
by Mouj Hijazi
November 10, 2026